創薬プロジェクトへの新しいハイスループットシステム—分子ディスプレイとコンビナトリアル・バイオエンジニアリングの集積・共役

DOI Web Site Web Site 被引用文献2件 参考文献15件
  • 植田 充美
    京都大学大学院農学研究科応用生命科学専攻

書誌事項

タイトル別名
  • Novel High-Throughput System for Production of New Medicines-Integration and Combination with Molecular Display and Combinatorial Bioengineering
  • 創薬プロジェクトへの新しいハイスループットシステム--分子ディスプレイとコンビナトリアル・バイオエンジニアリングの集積・共役
  • ソウヤク プロジェクト エ ノ アタラシイ ハイスループット システム ブンシ ディスプレイ ト コンビナトリアル バイオエンジニアリング ノ シュウセキ キョウヤク

この論文をさがす

説明

  To demonstrate the practical use of a novel high-throughput screening system by single cells constructed by the molecular display method, a yeast cell chip microchamber array was developed. As applications, peptides, peptidases, and antibodies were examined. Neurolysin originally recognizes substrates with six-amino-acid-long residues, cleaving a peptide bond in the center position of the substrate amino acid sequence. To alter the recognition of the P2' amino acid of substrates by neurolysin, six residues of neurolysin which might be involved in the formation of the neurolysin S2' subsite were individually and comprehensively substituted by semirational mutagenesis coupled with the yeast molecular display system. The protein libraries of mutant neurolysins were displayed on the yeast cell surface and screening was carried out using two fluorescence-quenching peptides, the matrix metalloproteinase-2/9- and MMP-3-specific substrates. Among mutant neurolysins, one mutant neurolysin with a marked change in substrate specificity was successfully obtained. Furthermore, skillful display of antibodies (H and L chains) on the cell surface of yeast cells suggested the possibility of new approach for the creation of tailor-made proteases beyond limitations of the traditional immunization approach. Accordingly, the combination of the molecular display and combinatorial bioengineering would lead to produce novel medicines.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 129 (11), 1277-1284, 2009-11-01

    公益社団法人 日本薬学会

被引用文献 (2)*注記

もっと見る

参考文献 (15)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ